Human medicines European public assessment report (EPAR): Kymriah, tisagenlecleucel, Date of authorisation: 23/08/2018, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Kymriah, tisagenlecleucel, Date of authorisation: 23/08/2018, Revision: 19, Status: Authorised
